Dr. Christopher Bird
Dr. Christopher Bird
Dr. Christopher Bird is Chief Medical Officer at Beckman Coulter Diagnostics. He brings more than 25 years of experience across diagnostics, molecular medicine and cell therapy, including leadership roles at Roche Diagnostics and BioPorto, as well as a founder for a CAR-T cell therapy company. He holds a DPhil in Molecular Immunology from the University of Oxford and a Master’s in Biochemistry and Molecular Biology from UCLA.

Articles

From Breakthroughs to Brain Health: How BRAINIAC Can Help Turn Alzheimer’s Innovation into Earlier Answers

From Breakthroughs to Brain Health: How BRAINIAC Can Help Turn Alzheimer’s Innovation into Earlier Answers